Company profile: Nivalis
1.1 - Company Overview
Company description
- Provider of clinical-stage pharmaceutical therapies designed to preserve intracellular S-nitrosoglutathione (GSNO), an endogenous molecule with cell signaling effects implicated in cystic fibrosis pathophysiology; developing a novel class of disease-modifying treatments, including lead candidate N91115 initially targeting CF patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nivalis
Primrose Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology research and development focused on creating treatments for polycystic kidney disease (PKD), a life-threatening genetic disorder affecting 600,000 Americans and 12.5 million people worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Primrose Therapeutics company profile →
Cydan
HQ: United States
Website
- Description: Provider of orphan drug accelerator services focused on identifying and de-risking compounds with therapeutic and commercial potential.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cydan company profile →
Soin Therapeutics
HQ: United States
Website
- Description: Provider of pharmaceutical drug development focused on new medications for rare, orphan diseases, including a novel formulation of low-dose naltrexone to treat CRPS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Soin Therapeutics company profile →
BioElectron
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioElectron company profile →
HemoShear
HQ: United States
Website
- Description: Provider of the REVEAL-Tx platform, a drug discovery system combining biological and computational models to accelerate development of treatments for rare disorders. Offerings include HST5040, a clinical candidate for Propionic Acidemia and Methylmalonic Acidemia, and a human tissue-based model of rare liver disease developed in collaboration with Takeda.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HemoShear company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nivalis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nivalis
2.2 - Growth funds investing in similar companies to Nivalis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nivalis
4.2 - Public trading comparable groups for Nivalis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →